Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Algert Global LLC

Algert Global LLC lessened its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 16.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 92,445 shares of the company's stock after selling 17,873 shares during the quarter. Algert Global LLC's holdings in Doximity were worth $4,028,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Sei Investments Co. grew its holdings in shares of Doximity by 36.5% during the 1st quarter. Sei Investments Co. now owns 35,010 shares of the company's stock valued at $942,000 after purchasing an additional 9,359 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in shares of Doximity by 22.7% during the first quarter. CANADA LIFE ASSURANCE Co now owns 80,464 shares of the company's stock worth $2,165,000 after buying an additional 14,862 shares in the last quarter. LRI Investments LLC bought a new stake in Doximity during the 1st quarter worth approximately $34,000. Price T Rowe Associates Inc. MD grew its stake in Doximity by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 559,826 shares of the company's stock worth $15,065,000 after purchasing an additional 2,190 shares during the period. Finally, Janus Henderson Group PLC lifted its position in Doximity by 33.5% in the 1st quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company's stock valued at $66,594,000 after acquiring an additional 621,590 shares in the last quarter. Institutional investors own 87.19% of the company's stock.

Doximity Stock Performance

DOCS stock traded up $4.78 during midday trading on Tuesday, reaching $53.54. 3,346,984 shares of the company traded hands, compared to its average volume of 1,758,369. The firm has a market capitalization of $9.99 billion, a price-to-earnings ratio of 60.95, a P/E/G ratio of 3.91 and a beta of 1.30. The business has a 50 day moving average of $44.83 and a 200-day moving average of $35.34. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75.

Analysts Set New Price Targets

Several research analysts have commented on the stock. JPMorgan Chase & Co. raised their price target on shares of Doximity from $30.00 to $48.00 and gave the company a "neutral" rating in a report on Thursday, November 21st. Barclays increased their price objective on Doximity from $52.00 to $75.00 and gave the company an "overweight" rating in a research note on Monday, November 11th. Morgan Stanley upgraded shares of Doximity from an "underweight" rating to an "equal weight" rating and upped their price target for the company from $33.00 to $53.00 in a report on Thursday, November 14th. Wells Fargo & Company raised shares of Doximity from an "underweight" rating to an "equal weight" rating and upped their price objective for the company from $19.00 to $41.00 in a research note on Friday, November 8th. Finally, Raymond James reiterated an "outperform" rating and issued a $65.00 price objective (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Eleven research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $52.27.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.